Copyright
©The Author(s) 2021.
World J Psychiatr. Oct 19, 2021; 11(10): 897-914
Published online Oct 19, 2021. doi: 10.5498/wjp.v11.i10.897
Published online Oct 19, 2021. doi: 10.5498/wjp.v11.i10.897
Ref. | Sleep outcomes measurements | Results |
Hammer et al[53] | Objective: QEEG (Z-score); Subjective: PSQI, ISI | Significant effect only for SMR: Decrease z-score; Significant effect only for IND: Decreased proportion of abnormal z-scores at all 19 sitesb, especially for deltab and betab bands; Significant effect for SMR and IND: (1) Decreased score for ISIb, for PSQIb: All participants finished under the threshold for insomnia (ISI < 10; PSQI < 5, except 1 at 6); and (2) Increased TSTb; Results of the 6-9 mo follow up: 5 out of 6 participants remained below the ISI threshold for insomnia; 3 of the 5 improved during the months following the end of the treatment |
Perez-Elvira et al[55] | Objective: QEEG; Subjective: Visual analogue scale on their symptoms | Significant effect: (1) Significant difference of 5.70% between pre- and post-QEEGs; (2) More probable to normalize then to get further away from normalizationa; and (3) Improvement of symptoms |
- Citation: Lambert-Beaudet F, Journault WG, Rudziavic Provençal A, Bastien CH. Neurofeedback for insomnia: Current state of research. World J Psychiatr 2021; 11(10): 897-914
- URL: https://www.wjgnet.com/2220-3206/full/v11/i10/897.htm
- DOI: https://dx.doi.org/10.5498/wjp.v11.i10.897